Medicinal Products

Feiba 25 U/ml prašak i otapalo za otopinu za infuziju

Name Feiba 25 U/ml prašak i otapalo za otopinu za infuziju
Former Name Feiba 500 U prašak i otapalo za otopinu za infuziju
Marketing Authorisation Number HR-H-241676463
Active Substance proteini ljudske plazme koji djeluju protiv inhibitora koagulacijskog faktora VIII
Composition 1 ml sadrži 25 U aktivnosti protiv inhibitora koagulacijskog faktora VIII
1 bočica sadrži 500 U aktivnosti protiv inhibitora koagulacijskog faktora VIII u 200 – 600 mg proteina ljudske plazme
Pharmaceutical Form prašak i otapalo za otopinu za infuziju
Manufacturer Takeda Manufacturing Austria AG, Beč, Austrija
Marketing Authorisation Holder Baxalta Innovations GmbH, Industriestrasse 67, Beč, Austrija
Marketing Authorisation Date 28.03.2018
MA Period of Validity unlimited
MA Revocation Date 13.02.2024*
Classification Number UP/I-530-09/17-02/736
Registration Number 381-12-01/70-18-06
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code B02BD03
Medicinal product marketed in the Croatia Trajni prekid opskrbe
SmPC download
PL download
Public Assessment Report download

*Note

Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act (Official Gazette No. 76/13), only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.

Packaging

Back